Table 2 Observed bile sCD14 levels by GBC case and gallstone control status.

From: Soluble cluster of differentiation 14 levels elevated in bile from gallbladder cancer cases from Shanghai, China

 

Controls (n = 117)

Cases (n = 41)

Stage I or II (n = 15)

Stage III or IV (n = 24)

n (%)

n (%)

OR (95% CI)

n (%)

OR (95% CI)

n (%)

OR (95% CI)

Tertiles

1st

38 (32.5)

8 (19.5)

1

3 (20.0)

1

4 (16.7)

1

2nd

39 (33.3)

9 (22.0)

1.06 (0.4–3.1)

1 (6.7)

0.3 (0.01–2.6)

8 (33.3)

1.9 (0.5–7.7)

3rd

40 (34.2)

24 (58.5)

3.01 (1.2–8.0)

11 (73.3)

3.3 (0.9–15.6)

12 (50.0)

3.2 (1.0–12.4)

p value

 

0.03

 

0.02

 

0.2

 

p trend

  

0.01

 

0.04

 

0.06

  1. Bile sCD14 cutoffs among GS controls: tertiles < 16,676 pg/mL (first), ≥ 16,676 and < 81,906.4 pg/mL (second), ≥ 81,906.4 pg/mL (third).
  2. Odds ratio adjusted for sex and age.
  3. p value: Fisher’s exact test; p trend: Wald test.